Investor ACT Capital Management, LLLP
13D/G Filings

This page shows a list of all the recent 13D/G filings made by ACT Capital Management, LLLP . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2020-12-09 13G/A HYRE / HyreCar Inc 860,000 230,000
2020-02-10 13G/A HYRE / HyreCar Inc 860,000 860,000
2020-02-08 13G/A HYRE / HyreCar Inc 860,000 860,000
2020-02-07 13G/A HYRE / HyreCar Inc 935,000 860,000
2020-02-07 13G/A SNGX / Soligenix, Inc. 1,506,500 1,221,499
2019-04-18 13G/A BBIG / Vinco Ventures, Inc. 333,803 214,454
2019-02-14 13G/A BBIG / Vinco Ventures, Inc. 333,803
2019-02-13 13G/A SNGX / Soligenix, Inc. 1,499,000 1,506,500
2019-01-04 13G HYRE / HyreCar Inc 935,000
2018-12-26 13G/A NVNO / enVVeno Medical Corporation 760,000 503,500
2018-08-10 13G/A AMPE / Ampio Pharmaceuticals, Inc. 4,675,500 1,210,785
2018-07-30 13G/A SNGX / Soligenix, Inc. 872,000 1,499,000
2018-06-15 13G NVNO / enVVeno Medical Corporation 760,000
2018-05-09 13G US28103E1064 / Edison Nation, Inc. 405,000
2018-02-13 13G/A AMPE / Ampio Pharmaceuticals, Inc. 4,150,000 4,675,500
2018-02-13 13G/A SNGX / Soligenix, Inc. 872,000 872,000
2017-11-07 13G SNGX / Soligenix, Inc. 872,000
2017-10-27 13G AMPE / Ampio Pharmaceuticals, Inc. 2,277,500 4,150,000
2017-06-16 13G/A CRDS / Crossroads Systems, Inc. 66,553 59,053
2017-01-23 13G/A ADGL / AllDigital Holdings, Inc. 2,621,969 0
2017-01-10 13G/A CRDS / Crossroads Systems, Inc. 2,316,006 66,553
2017-01-06 13G/A MFON / Mobivity Holdings Corp. 1,749,916 1,734,916
2016-07-22 13G/A AMPE / Ampio Pharmaceuticals, Inc. 3,692,500 2,277,500
2016-02-12 13G/A CRDS / Crossroads Systems, Inc. 2,316,006
2016-02-08 13G/A MFON / Mobivity Holdings Corp. 1,749,916
2016-01-28 13G/A AMPE / Ampio Pharmaceuticals, Inc. 3,692,500
2016-01-27 13G/A ADGL / AllDigital Holdings, Inc. 2,621,969
2016-01-25 13G/A MYMD / MyMD Pharmaceuticals, Inc. 213,500
2015-02-09 13G/A ADGL / AllDigital Holdings, Inc. 2,621,969
2015-02-06 13G/A AHROQ / Atheronova Inc 502,707
2015-02-05 13G/A AMPE / Ampio Pharmaceuticals, Inc. 3,906,000
2015-02-04 13G/A CRDS / Crossroads Systems, Inc. 1,969,969
2015-01-30 13G/A MFON / Mobivity Holdings Corp. 1,945,800
2015-01-23 13G/A MYMD / MyMD Pharmaceuticals, Inc. 378,500
2015-01-22 13G/A GIG / GigCapital7 Corp. 1,591,000
2014-02-25 13G MYMD / MyMD Pharmaceuticals, Inc. 280,100
2014-02-13 13G/A AMPE / Ampio Pharmaceuticals, Inc. 3,100,000
2014-02-13 13G/A CRDS / Crossroads Systems, Inc. 1,904,123
2014-02-13 13G/A AHRO / Authentic Holdings, Inc. 4,401,300
2014-02-13 13G ADGL / AllDigital Holdings, Inc. 2,621,969
2014-02-13 13G/A 7,006,129
2014-02-12 13G/A GIG / GigCapital7 Corp. 1,598,500
2014-02-12 13G/A MFON / Mobivity Holdings Corp. 1,677,416
2013-08-01 13G MFON / Mobivity Holdings Corp. 10,064,576
2013-05-08 13G/A AMPE / Ampio Pharmaceuticals, Inc. 2,357,500
2013-04-30 13G/A CRDS / Crossroads Systems, Inc. 1,934,790
2013-04-09 13G/A AHROQ / Atheronova Inc 4,255,000
2013-02-14 13G/A 6,806,129
2013-02-06 13G/A CRDS / Crossroads Systems, Inc. 866,242
2013-02-01 13G AHROQ / Atheronova Inc 2,700,000
2013-01-29 13G/A GIG / GigCapital7 Corp. 1,793,000
2013-01-29 13G AMPE / Ampio Pharmaceuticals, Inc. 1,896,500
2012-02-14 13G/A 3,916,379
2012-02-09 13G CRDS / Crossroads Systems, Inc. 806,937
2012-01-31 13G/A GIG / GigCapital7 Corp. 1,700,000